semaglutide ckd in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial 💉 The FDA has approved

Williams, Aikaterini Eleftheriadou, Uazman Alam, Daniel J

Unlike oral semaglutide (Rybelsus), which co-formulates the semaglutide peptide with the absorption enhancer SNAC and requires patients to take the medication on an empty stomach with no more than 4 ounces of water and then wait at least 30 minutes before eating, orforglipron achieves oral bioavailability of approximately 79% without any such restrictions

Retatrutide is the drug Lilly is using to defend that lead

Enhanced Lifestyle Changes: Semaglutide is not a standalone solution for weight loss but rather a supportive tool that complements lifestyle changes

In 2025, the litigation strategy shifted from medical spas to large-scale 503B operators

For patients on ACE inhibitors or ARBs, regular monitoring of serum creatinine and potassium levels is advised to catch any issues early